Abstract
Preterm birth is delivery before 37 completed weeks. A study was conducted to evaluate the association of maternal serum concentrations of selenium, copper, and zinc, and preterm birth. There were 181 women in this nested case-control study, 90/181 (49.7%) term and 91/181 (50.3%) preterm pregnant women. The overall mean serum concentration of selenium was 77.0; SD 19.4µg/L, copper was 2.50; SD 0.52 mg/L and zinc was 0.77; SD 0.20 mg/L with reference values of 47-142µg/L, 0.76-1.59mg/L and 0.59-1.11 mg/L, respectively. For preterm birth, mean serum concentrations for selenium was 79.7; SD 21.6µg/L, copper was 2.61; SD 0.57 mg/L, and zinc was 0.81; SD 0.20 mg/L compared to that of term births: selenium (74.2; SD 16.5µg/L; p=0.058), copper (2.39; SD 0.43 mg/L; p = 0.004), and zinc (0.73; SD 0.19 mg/L; p = 0.006) respectively. In adjusted analysis, every unit increase in maternal selenium concentrations gave increased odds of being a case OR 1.01 (95% CI: 0.99; 1.03), p=0.234, copper OR 1.62 (95% CI: 0.80; 3.32); p = 0.184, zinc OR 6.88 (95% CI: 1.25; 43.67); p=0.032. Results show that there was no deficiency of selenium, and zinc; and high serum concentrations of copper in pregnancy. Preterm birth was associated with higher maternal serum concentrations of copper and zinc.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding was received
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available on request
